Kodiak Sciences Inc (KOD) Stock Analysis
Verdict: WATCH (do not buy)
GLOW2 Phase 3 momentum inflates market cap to $5.9B, but an 8.6-month cash runway ($125.9M) poses imminent dilution risk.
Investment score: 43/100
Analysis as of
Is Kodiak Sciences Inc stock worth reviewing? AI model thesis
The model score of 43/100 falls in the HOLD range. The central thesis and factor breakdown explain the assessment.
7-factor investment score
- Valuation: 25/100 (weight 20%)
- Financial Health: 20/100 (weight 15%)
- Technical Momentum: 82/100 (weight 15%)
- Earnings Quality: 45/100 (weight 15%)
- Insider Sentiment: 35/100 (weight 10%)
- Analyst Consensus: 75/100 (weight 10%)
- Risk-Adjusted Return: 30/100 (weight 15%)
Kodiak Sciences Inc opportunities and risks
What speaks for KOD
- Positive Phase 3 GLOW2 trial results accelerate Zenkuda regulatory path
What speaks against KOD
- Imminent equity dilution driven by an 8.6-month cash runway
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| KOD | n/a | 0.0x | n/a | 0.0% | 0.0% | -2.7% |
| IMVT | n/a | 967.3x | n/a | 97.1% | -7585.9% | -6.0% |
| IOVA | n/a | 19.4x | n/a | 116.3% | -89.1% | -4.7% |
| RYTM | n/a | 26.4x | n/a | 89.0% | -85.6% | -2.4% |
| CGON | n/a | 973.1x | n/a | -82.7% | -3602.7% | -3.0% |
| ORKA | n/a | 0.0x | n/a | 0.0% | 0.0% | -2.0% |
| Peer median | n/a | 26.4x | n/a | 89.0% | -89.1% | -3.0% |
Frequently asked questions about Kodiak Sciences Inc (KOD)
Is KOD stock a good investment?
The cached TradeMates AI model rates Kodiak Sciences Inc as WATCH (do not buy) with an investment score of 43/100. The model score of 43/100 falls in the HOLD range. The central thesis and factor breakdown explain the assessment. This is algorithmic model output, not personal investment advice.
Is KOD stock a buy?
The TradeMates model verdict for KOD is WATCH (do not buy) with an investment score of 43/100. Treat this as a model signal to review, not a personal buy recommendation.